Publicaciones en las que colabora con Laura Judith Marcos Zambrano (35)

2020

  1. Corrigendum to ‘Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect’ [Clinical Microbiology and Infection, Volume 24, (Issue 12) (December 2018) Pages 1343.e1-1343.e4](S1198743X18305214)(10.1016/j.cmi.2018.07.006)

    Clinical Microbiology and Infection

  2. Corrigendum to “Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect” [Clin Microbiol Infect 24 (12) (December 2018) 1343.e1-1343.e4](10.1016/j.cmi.2018.07.006)

    Clinical Microbiology and Infection

  3. Erratum: Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect (Clinical Microbiology and Infection (2018) 24(12) (1343.e1–1343.e4), (S1198743X18305214), (10.1016/j.cmi.2018.07.006))

    Clinical Microbiology and Infection

2019

  1. Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 3, pp. 607-614

2018

  1. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

  2. Is biofilm production a prognostic marker in adults with candidaemia?

    Clinical Microbiology and Infection, Vol. 24, Núm. 9, pp. 1010-1015

  3. Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect

    Clinical Microbiology and Infection, Vol. 24, Núm. 12, pp. 1343.e1-1343.e4

  4. Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata

    Medical Mycology, Vol. 56, Núm. 7, pp. 903-906

  5. Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical candida glabrata isolates

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 3

  6. Resistance to echinocandins in candida can be detected by performing the etest directly on blood culture samples

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 6

2017

  1. Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 7

  2. Frequency of the paradoxical effect measured using the EUCAST procedure with micafungin, anidulafungin, and caspofungin against Candida species isolates causing candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 1

  3. In vitro exposure to increasing micafungin concentrations easily promotes echinocandin resistance in Candida glabrata isolates

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2

  4. Las placas de agar dextrosado de Sabouraud con fluconazol no son útiles para la detección de resistencia en Candida albicans

    Revista Espanola de Quimioterapia, Vol. 30, Núm. 2, pp. 127-130

  5. The etest performed directly on blood culture bottles is a reliable tool for detection of fluconazole-resistant Candida albicans isolates

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 7

  6. The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 1969-1976

2016

  1. Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in Echinocandin-Resistant yeast species

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 6, pp. 3579-3586

  2. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms

    The Journal of antimicrobial chemotherapy, Vol. 71, Núm. 9, pp. 2498-2501

  3. Erratum for Marcos-Zambrano et al., Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center

    Antimicrobial Agents and Chemotherapy

  4. Erratum for Marcos-Zambrano et al., Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin

    Antimicrobial Agents and Chemotherapy